Fundraising FoxVeralox
acquired by Cadrenal Therapeutics10 known investors
Find your way into Veralox
Acquired by Cadrenal Therapeutics, Inc. December 2025 · $200K ($200,000 at closing plus assumed liabilities and contingent milestone/royalty payments) · source ↗
Developing novel treatments based on the 12-LOX pathway for immuno-inflammatory diseases.
Investors · 10
How we know: Hatteras Venture Partners's portfolio page · a partner's Signal profile · funding news · prnewswire.com · the VCSheet dataset · Not right? Tell us
How we know: Pappas Capital's portfolio page · Not right? Tell us
How we know: Sanofi Ventures's portfolio page · funding news · prnewswire.com · Not right? Tell us
How we know: funding news · prnewswire.com · Not right? Tell us
How we know: funding news · prnewswire.com · Not right? Tell us
How we know: funding news · prnewswire.com · Not right? Tell us
How we know: biobuzz.io · Not right? Tell us
How we know: funding news · biobuzz.io · Not right? Tell us
How we know: funding news · prnewswire.com · Not right? Tell us
How we know: funding news · prnewswire.com · Not right? Tell us
Founder mafia
3 people who came through Veralox went on to found or lead other companies.
Non-dilutive funding · 2 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase ISTTR | 2020 | $300K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2018 | $319.1K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- What does Veralox do?
- Developing novel treatments based on the 12-LOX pathway for immuno-inflammatory diseases.
- Who are Veralox's investors?
- Veralox's investors include Hatteras Venture Partners, Pappas Capital, Sanofi Ventures, Alexandria, Genesys Capital, JDRF T1D Fund, NYBC Ventures, Pappas Capital and 2 more.
- Who acquired Veralox?
- Veralox was acquired by Cadrenal Therapeutics.